Antihistamines and Itch
Antihistamines and Itch
复制标题
DOI:
10.1007/978-3-662-44605-8_15
复制
发表时间:
2015-01-01
期刊:
影响因子:
--
通讯作者:
Greenspan, Andrew J.
中科院分区:
文献类型:
--
作者:
Thurmond, Robin L.;Kazerouni, Kayvan;Greenspan, Andrew J.
Histamine is one of the best-characterized pruritogens in humans. It is known to play a role in pruritus associated with urticaria as well as ocular and nasal allergic reactions. Histamine mediates its effect via four receptors. Antihistamines that block the activation of the histamine H-1 receptor, H1R, have been shown to be effective therapeutics for the treatment of pruritus associated with urticaria, allergic rhinitis, and allergic conjunctivitis. However, their efficacy in other pruritic diseases such as atopic dermatitis and psoriasis is limited. The other histamine receptors may also play a role in pruritus, with the exception of the histamine H-2 receptor, H2R. Preclinical evidence indicates that local antagonism of the histamine H-3 receptor, H3R, can induce scratching perhaps via blocking inhibitory neuronal signals. The histamine H-4 receptor, H4R, has received a significant amount of attention as to its role in mediating pruritic signals. Indeed, it has now been shown that a selective H4R antagonist can inhibit histamine-induced itch in humans. This clinical result, in conjunction with efficacy in various preclinical pruritus models, points to the therapeutic potential of H4R antagonists for the treatment of pruritus not controlled by antihistamines that target the H1R.